Lymphocyte Engineering Conference, Madrid 2018
             
KEYNOTE SPEAKERS

malcolm brenner
Center for cell and gene therapy, texas children`s hospital
Usa
Carl June
perelman School of medicine, university of pennsylvania
usa

WELCOME TO THE INTERNATIONAL CONFERENCE
ON LYMPHOCYTE ENGINEERING

The International Conference on Lymphocyte Engineering (ICLE 2018) will provide a dedicated platform to advance research, clinical translation and treatment in immuno-gene therapy. ICLE brings together immunotherapy with cell and gene therapy to foster interdisciplinary collaborations, deepening the connection between basic and clinical research across related disease specialties: oncology, pathogenic diseases, autoimmunity, immunodeficiencies and others.

 With unprecedented success from more than 200 clinical trials, the recent increase in investment funding, and FDA approvals of CAR-T therapies, lymphocyte engineering has a potentially significant role in the future of healthcare. Whether you are a scientist, clinical researcher, part of a start-up or an established industry company, ICLE 2018 will be your opportunity to network and discuss immuno-gene therapy with those as excited and passionate about the future as you.

 Join us in Madrid, 13-15 September 2018!



Leaders & Speakers



STAY UP-TO-DATE
Subscribe to our newsletter to get all the updates on the Conference




CONNECT WITH US

#ICLE2018


   



sponsorship opportunities